Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Files $20M Shelf Registration

NEW YORK (GenomeWeb) – Response Genetics has filed a shelf registration with the US Securities and Exchange Commission to offer up to $20 million in securities from time to time.

Securities that may be offered include Response's common stock, preferred stock, and warrants, the company said in its SEC document. Proceeds from any offering will go toward general corporate purposes, such as the funding of its operations, working capital, R&D efforts, capital expenditures, and strategic investments.

In December, Response launched a $4.8 million public offering of its common stock.

Late last month, the Los Angeles-based molecular diagnostics firm said that it received a warning letter from the Nasdaq that its shares had closed below a minimum $1 per share for 30 consecutive business day, putting Response in jeopardy of having its stock delisted from the Nasdaq Capital Market. The firm has until Dec. 17 to regain compliance.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.